Interscalene Brachial Plexus Block with Liposomal Bupivacaine versus Standard Bupivacaine with Perineural Dexamethasone: A Noninferiority Trial: Erratum

Erratum| May 2022 Interscalene Brachial Plexus Block with Liposomal Bupivacaine versus Standard Bupivacaine with Perineural Dexamethasone: A Noninferiority Trial: Erratum Anesthesiology Newly Published on May 2022. doi: https://doi.org/10.1097/ALN.0000000000004255 Connected Content Article: Interscalene Brachial Plexus Block with Liposomal Bupivacaine versus Standard Bupivacaine with Perineural Dexamethasone: A Noninferiority Trial Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Twitter LinkedIn Cite Icon Cite Get Permissions Search Site Citation Interscalene Brachial Plexus Block with Liposomal Bupivacaine versus Standard Bupivacaine with Perineural Dexamethasone: A Noninferiority Trial: Erratum. Anesthesiology Newly Published on May 3, 2022. doi: https://doi.org/10.1097/ALN.0000000000004255 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll PublicationsAnesthesiology Search Advanced Search The last sentence in the Results section paragraph on the primary outcome (page 438) was incorrect as published: “Superiority testing (one-sided t test) demonstrated that the average numerical rating scale pain score over 3 days postoperatively for the liposomal bupivacaine group was not superior to that of the bupivacaine with dexamethasone group (P = 0.998).” There was an error in the P-value calculation as originally published. The corrected sentence should read, “In addition, based on a manuscript peer reviewer request for superiority testing via post hoc analysis, superiority testing (two-tailed two-sample t test) was performed and found that the average numerical rating scale pain score over 72 h postoperatively was statistically significantly lower for the liposomal bupivacaine group compared to the bupivacaine with dexamethasone group (P = 0.002). However, the mean average numerical rating scale pain score over 72 h difference was 1.1, which is below the... View Original Article You do not currently have access to this content.